• Contact info@abtriva.com for inquiries and orders.
  • Chinese (Simplified)

  • English

  • German

  • Korean

  • Spanish

United States (English / $ USD)

Rabbit anti-Human SCRN2 Polyclonal Antibody

The antibody against SCRN2 was raised in rabbit using the Recombinant Human Secernin-2 protein (176-425AA) as the immunogen. This antibody exists as a non-conjugated isotype IgG, Antigen affinity purified. This antibody has been validated on ELISA, IHC.

ADC-16904A

The antibody against SCRN2 was raised in rabbit using the Recombinant Human Secernin-2 protein (176-425AA) as the immunogen. This antibody exists as a non-conjugated isotype IgG, Antigen affinity purified. This antibody has been validated on ELISA, IHC.

$299.00

Number
Order Exclusive Products Now

Request a Quote
High Purity LevelsPrecision and ReliabilityCustomization Options

Specifications


Cat.No ADC-16904A ClonalityPolyclonal
Host SpeciesRabbitTarget NameSCRN2
Target Synonymsscrn2 antibody; SCRN2_HUMAN antibody; Secernin 2 antibody; Secernin-2 antibody; Ses2 antibodyFormLiquid
Species ReactivityHumanIsotypeIgG
Storage Buffer50% Glycerol, PBS with 0.02% sodium azide, pH7.3.Purification MethodAntigen affinity purified
ConjugateNon-conjugatedApplicationELISA, IHC
StorageUpon receipt

Immunogen Information


Immunogen DescriptionRecombinant Human Secernin-2 protein (176-425AA)Target SpeciesHuman
Immunogen SequenceComplete sequences for the immunogen, target protein, and peptides are available upon request.Uniprot IDQ96FV2
Background Information
  • Uniprot Id

    Q96FV2

  • Target Species

    Human

  • Target Name

    SCRN2

  • Target Full Name

    Secernin-2

  • Target Synonyms

    scrn2; SCRN2_HUMAN; Secernin 2; Secernin-2; Ses2

  • Target Background

    Predicted to enable cysteine-type exopeptidase activity and dipeptidase activity. Predicted to be involved in proteolysis. Located in extracellular exosome.

Inquire Rabbit anti-Human SCRN2 Polyclonal Antibody Now



AbTriva respects your privacy and protects your personal data in accordance with AbTriva. For more information, please see our data protection statement. *

Notification